Literature DB >> 15922893

Elevation of plasma osteopontin level in patients with undifferentiated nasopharyngeal carcinoma.

T S Wong1, D L-W Kwong, J Sham, W I Wei, Y L Kwong, A P-W Yuen.   

Abstract

AIMS: We evaluated the clinicopathologic relevance of plasma osteopontin (OPN) level in nasopharyngeal carcinoma patients.
METHODS: Seventy-two plasma samples were collected from patients with undifferentiated nasopharyngeal carcinoma (NPC) before radiotherapy. Plasma OPN level was determined by quantitative sandwich enzyme immunoassay. The plasma OPN level was evaluated for its clinicopathologic relevance.
RESULTS: The mean plasma OPN level was significantly higher in NPC patients than in normal controls (184.66 vs 75.89 ng/ml, p<0.001). In addition, high OPN level was found in the patients with advanced cancer and was correlated with neck node metastasis (p<0.05).
CONCLUSIONS: Our findings indicated a potential role of OPN in the pathogenesis and nodal metastasis of undifferentiated NPC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15922893     DOI: 10.1016/j.ejso.2005.01.005

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  9 in total

1.  Serum levels of osteopontin as a prognostic factor in patients with oral squamous cell carcinoma.

Authors:  Maryam Mardani; Azadeh Andisheh-Tadbir; Bijan Khademi; Mohammad Javad Fattahi; Shapour Shafiee; Maryam Asad-Zadeh
Journal:  Tumour Biol       Date:  2013-12-14

2.  Elevated plasma osteopontin as marker for distant metastases and poor survival in patients with renal cell carcinoma.

Authors:  Azizbek Ramankulov; Michael Lein; Glen Kristiansen; Hellmuth-A Meyer; Stefan A Loening; Klaus Jung
Journal:  J Cancer Res Clin Oncol       Date:  2007-05-04       Impact factor: 4.553

3.  Correlation between OPN gene polymorphisms and the risk of nasopharyngeal carcinoma.

Authors:  Jun-li Wang; Le-gen Nong; Yu-jin Tang; Ye-sheng Wei; Feng-lian Yang; Chun-fang Wang
Journal:  Med Oncol       Date:  2014-06-10       Impact factor: 3.064

4.  Elevated circulating levels of osteopontin are associated with metastasis in advanced non-small cell lung cancer.

Authors:  Yong Liang; Hui Li; Bin Hu; Xing Chen; Jin-Bai Miao; Tong Li; Bin You; Qi-Rui Chen; Yi-Li Fu; Yang Wang; Sheng-Cai Hou
Journal:  Chin J Cancer Res       Date:  2011-03       Impact factor: 5.087

5.  Increasing incidence of Epstein-Barr virus-related nasopharyngeal carcinoma in the United States.

Authors:  Ilona Argirion; Katie R Zarins; Julie J Ruterbusch; Patravoot Vatanasapt; Hutcha Sriplung; Erlene K Seymour; Laura S Rozek
Journal:  Cancer       Date:  2019-09-16       Impact factor: 6.860

6.  Plasma osteopontin levels in patients with head and neck cancer and cervix cancer are critically dependent on the choice of ELISA system.

Authors:  Dirk Vordermark; Harun M Said; Astrid Katzer; Thomas Kuhnt; Gabriele Hänsgen; Jürgen Dunst; Michael Flentje; Matthias Bache
Journal:  BMC Cancer       Date:  2006-08-15       Impact factor: 4.430

Review 7.  Nasopharyngeal carcinoma: molecular biomarker discovery and progress.

Authors:  William Chi-Shing Cho
Journal:  Mol Cancer       Date:  2007-01-02       Impact factor: 27.401

8.  The value of plasma hypoxia markers for predicting imaging-based hypoxia in patients with head-and-neck cancers undergoing definitive chemoradiation.

Authors:  Alexander Rühle; Anca-L Grosu; Nicole Wiedenmann; Juri Ruf; Birgit Bieber; Raluca Stoian; Andreas R Thomsen; Eleni Gkika; Peter Vaupel; Dimos Baltas; Wolfgang A Weber; Michael Mix; Nils H Nicolay
Journal:  Clin Transl Radiat Oncol       Date:  2022-02-21

9.  The inhibitory effects of extracellular ATP on the growth of nasopharyngeal carcinoma cells via P2Y2 receptor and osteopontin.

Authors:  Guang Yang; Shenghong Zhang; Yanling Zhang; Qiming Zhou; Sheng Peng; Tao Zhang; Changfu Yang; Zhenyu Zhu; Fujun Zhang
Journal:  J Exp Clin Cancer Res       Date:  2014-06-24
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.